|
|
| Line 35: |
Line 35: |
|
| |
|
| *'''Medical therapy''', '''Interventions, Surgery, Primary Prevention, Secondary Prevention, Cost Effectiveness of Therapy, Future or Investigational Therapy'''<br /> | | *'''Medical therapy''', '''Interventions, Surgery, Primary Prevention, Secondary Prevention, Cost Effectiveness of Therapy, Future or Investigational Therapy'''<br /> |
|
| |
| ==Special Patient Populations==
| |
| [[Hypertrophic cardiomyopathy in special clinical scenarios#2011 ACCF/AHA Guideline Recommendations: Asymptomatic Patients (DO NOT EDIT)|Asymptomatic Patients]] | [[Hypertrophic cardiomyopathy management during childhood | Management During Childhood]] | [[Hypertrophic cardiomyopathy in special clinical scenarios#Management of HCM in presence of hypotension and cardiovascular collapse|Hypotension/Cardiovascular collapse]] | [[Hypertrophic cardiomyopathy management during pregnancy|Pregnancy]]
| |
|
| |
| ==2011 ACCF/AHA Guideline Recommendations==
| |
| ====Diagnostic testing:====
| |
| [[Hypertrophic cardiomyopathy electrocardiogram#2011 ACCF/AHA Guideline Recommendations: Electrocardiography (DO NOT EDIT)|Electrocardiogram]]
| |
| | [[Hypertrophic cardiomyopathy echocardiography#2011 ACCF/AHA Guideline Recommendations: Echocardiography|Echocardiography]]
| |
| | [[Hypertrophic cardiomyopathy electrocardiogram#Stress Test|Stress Testing]]
| |
| | [[Hypertrophic_cardiomyopathy_MRI#2011_ACCF.2FAHA_Guideline_Recommendations:_Cardiac_Magnetic_Resonance|Cardiac Magnetic Resonance]]
| |
| | [[Hypertrophic_cardiomyopathy_CT#2011_ACCF.2FAHA_Guideline_Recommendations:_Detection_of_Concomitant_Coronary_Disease|Cardiac CT]]
| |
| | [[Hypertrophic cardiomyopathy other imaging findings#Positron Emission Tomography|Positron Emission Tomography]]
| |
|
| |
| ====Management:====
| |
| *'''Asymptomatic patients:''' [[Hypertrophic cardiomyopathy in special clinical scenarios#2011 ACCF/AHA Guideline Recommendations: Asymptomatic Patients (DO NOT EDIT) |Asymptomatic patients]]
| |
|
| |
| *'''Symptomatic patints:''' [[Hypertrophic cardiomyopathy medical treatment#2011 ACCF/AHA Guideline Recommendations: Pharmacologic Management in Symptomatic Patients (DO NOT EDIT)|Pharmacologic Management]]
| |
| | [[Hypertrophic cardiomyopathy interventional cardiology|Invasive Therapies]]
| |
| | [[Hypertrophic cardiomyopathy alcohol septal ablation#2011 ACCF/AHA Guideline Recommendations: Alcohol Septal Ablation (DO NOT EDIT)|Alcohol septal ablation]]
| |
| | [[Hypertrophic cardiomyopathy septal myectomy#2011 ACCF/AHA Guideline Recommendations: Septal Myectomy (DO NOT EDIT)|Septal Myectomy]]
| |
| | [[Hypertrophic cardiomyopathy ventricular pacing#2011 ACCF/AHA Guideline Recommendations: Pacing (DO NOT EDIT)|Pacing]]
| |
| | [[Hypertrophic cardiomyopathy automatic implantable cardiac defibrillator placement#2011 ACCF/AHA Guideline Recommendations: Selection of Patients for ICDs (DO NOT EDIT)|Selection of Patients for ICDs]]
| |
| | [[Hypertrophic cardiomyopathy automatic implantable cardiac defibrillator placement#2011 ACCF/AHA Guideline Recommendations: Selection of ICD Device Type (DO NOT EDIT)|Selection of ICD-Device type]]
| |
| | [[Hypertrophic cardiomyopathy surgical treatment#Cardiac transplantation|Selection of Patients for Heart Transplantation]]
| |
|
| |
| *'''Special Clinical Scenarios:''' [[Hypertrophic cardiomyopathy in special clinical scenarios#2011 ACCF/AHA Guideline Recommendations: Patients With LV Systolic Dysfunction (DO NOT EDIT)|Patients With LV Systolic Dysfunction]] | [[Hypertrophic cardiomyopathy risk factors for sudden death#2011 ACCF/AHA Guideline Recommendations: SCD Risk Stratification (DO NOT EDIT) |Sudden cardiac death Risk Stratification]] | [[Hypertrophic cardiomyopathy activities and circumstances to avoid#2011 AHA/ACC Guidelines Recommendations- Participation in Competitive or Recreational Sports and Physical Activity (DO NOT EDIT)|Participation in Competitive or Recreational Sports and Physical Activity]] | [[Hypertrophic cardiomyopathy medical treatment#2011 AHA/ACC Guidelines Recommendations- Management of Atrial Fibrillation in HCM (DO NOT EDIT)|Management of Atrial Fibrillation]] | [[Hypertrophic cardiomyopathy management during pregnancy#2011 ACCF/AHA Guideline Recommendations: Pregnancy/Delivery (DO NOT EDIT)|Pregnancy/Delivery]] | [[Hypertrophic cardiomyopathy with coronary artery disease#2011 ACCF/AHA Guideline Recommendations: Detection of Concomitant Coronary Disease (DO NOT EDIT)|Concomitant Coronary Disease]]
| |
|
| |
|
| ==Resources== | | ==Resources== |
For patient information click here
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Soroush Seifirad, M.D.[2]
Synonyms and keywords: Hypertrophic cardiomyopathy or HCM, Asymmetric septal hypertrophy or ASH, Hypertrophic obstructive cardiomyopathy, HOCM, Idiopathic hypertrophic subaortic stenosis or IHSS, familial isolated hypertrophic obstructive cardiomyopathy, familial isolated hypertrophic subaortic stenosis, familial or idiopathic hypertrophic subaortic stenosis, familial or idiopathic hypertrophic obstructive cardiomyopathy, primitive hypertrophic obstructive cardiomyopathy, primitive hypertrophic subaortic stenosis, muscular subaortic stenosis, apical hypertrophic cardiomyopathy, which is also known as nonobstructive hypertrophic cardiomyopathy and Japanese variant hypertrophic cardiomyopathy or the Yamaguchi variant (since the first cases described were all in individuals of Japanese descent)
Historical Perspective
Pathophysiology
Risk Factors
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Study of Choice| History and Symptoms | Physical examination | Laboratory findings | Electrocardiogram | X Ray | Echocardiography and Ultrasound | CT Scan | MRI |Other Imaging Findings | Other Diagnostic Studies.
Treatment
- Medical therapy, Interventions, Surgery, Primary Prevention, Secondary Prevention, Cost Effectiveness of Therapy, Future or Investigational Therapy
Resources
Template:WikiDoc Sources
